These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 38646869)

  • 1.
    Liu T; Zhou L; Li X; Song W; Liu Y; Wu S; Wang P; Dai X; Shi L
    J Agric Food Chem; 2024 May; 72(17):9880-9892. PubMed ID: 38646869
    [No Abstract]   [Full Text] [Related]  

  • 2. Polysaccharides from Polygonatum kingianum improve glucose and lipid metabolism in rats fed a high fat diet.
    Gu W; Wang Y; Zeng L; Dong J; Bi Q; Yang X; Che Y; He S; Yu J
    Biomed Pharmacother; 2020 May; 125():109910. PubMed ID: 32028238
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Early intervention with probiotics and metformin alleviates liver injury in NAFLD rats via targeting gut microbiota dysbiosis and p-AKT/mTOR/LC-3II pathways.
    Seif El-Din SH; Salem MB; El-Lakkany NM; Hammam OA; Nasr SM; Okasha H; Ahmed LA; Saleh S; Botros SS
    Hum Exp Toxicol; 2021 Sep; 40(9):1496-1509. PubMed ID: 33678036
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Distinct prebiotic effects of polysaccharide fractions from Polygonatum kingianum on gut microbiota.
    Zhang N; Zhang C; Zhang Y; Ma Z; Li L; Liu W
    Int J Biol Macromol; 2024 Nov; 279(Pt 4):135568. PubMed ID: 39270897
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intake of total saponins and polysaccharides from Polygonatum kingianum affects the gut microbiota in diabetic rats.
    Yan H; Lu J; Wang Y; Gu W; Yang X; Yu J
    Phytomedicine; 2017 Mar; 26():45-54. PubMed ID: 28257664
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lactobacillus reuteri DSM 17938 alleviates d-galactosamine-induced liver failure in rats.
    Jiang H; Yan R; Wang K; Wang Q; Chen X; Chen L; Li L; Lv L
    Biomed Pharmacother; 2021 Jan; 133():111000. PubMed ID: 33202285
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multi-omics insights into anti-colitis benefits of the synbiotic and postbiotic derived from wheat bran arabinoxylan and Limosilactobacillus reuteri.
    Zhou L; Song W; Liu T; Yan T; He Z; He W; Lv J; Zhang S; Dai X; Yuan L; Shi L
    Int J Biol Macromol; 2024 Oct; 278(Pt 3):134860. PubMed ID: 39163956
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lactobacillus reuteri improves gut barrier function and affects diurnal variation of the gut microbiota in mice fed a high-fat diet.
    Li S; Qi C; Zhu H; Yu R; Xie C; Peng Y; Yin SW; Fan J; Zhao S; Sun J
    Food Funct; 2019 Aug; 10(8):4705-4715. PubMed ID: 31304501
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of Limosilactobacillus reuteri strains PTA-126787 and PTA-126788 on intestinal barrier integrity and immune homeostasis in an alcohol-induced leaky gut model.
    Gangaiah D; Gu M; Zaparte A; Will O; Dolan LC; Goering A; Pillai J; Mane SP; Plata G; Helmes EB; Welsh DA; Mahajan AK
    Sci Rep; 2024 Aug; 14(1):19584. PubMed ID: 39179898
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oat-based postbiotics ameliorate high-sucrose induced liver injury and colitis susceptibility by modulating fatty acids metabolism and gut microbiota.
    Song W; Wen R; Liu T; Zhou L; Wang G; Dai X; Shi L
    J Nutr Biochem; 2024 Mar; 125():109553. PubMed ID: 38147914
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of Maternal Gut Microbiota-Targeted Therapy on the Programming of Nonalcoholic Fatty Liver Disease in Dams and Fetuses, Related to a Prenatal High-Fat Diet.
    Yu HR; Sheen JM; Hou CY; Lin IC; Huang LT; Tain YL; Cheng HH; Lai YJ; Lin YJ; Tiao MM; Tsai CC
    Nutrients; 2022 Sep; 14(19):. PubMed ID: 36235659
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The prevention effect of Limosilactobacillus reuteri on acute kidney injury by regulating gut microbiota.
    Yang Z; Ni J; Sun X; Cui Q; Zhang X; Zhang M; Zhu X; Wu Z; Tang C; Zhu J; Mao H; Liu K; Wang C; Xing C; Zhu J
    Microbiol Immunol; 2024 Jul; 68(7):213-223. PubMed ID: 38747013
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Heat-killed and live Lactobacillus reuteri GMNL-263 exhibit similar effects on improving metabolic functions in high-fat diet-induced obese rats.
    Hsieh FC; Lan CC; Huang TY; Chen KW; Chai CY; Chen WT; Fang AH; Chen YH; Wu CS
    Food Funct; 2016 May; 7(5):2374-88. PubMed ID: 27163114
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modulating effects of heat-killed and live
    Ali MS; Lee EB; Quah Y; Sayem SAJ; Abbas MA; Suk K; Lee SJ; Park SC
    Vet Q; 2024 Dec; 44(1):1-18. PubMed ID: 38682319
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of Potential Probiotic Strains on the Fecal Microbiota and Metabolites of D-Galactose-Induced Aging Rats Fed with High-Fat Diet.
    Lew LC; Hor YY; Jaafar MH; Lau AS; Khoo BY; Sasidharan S; Choi SB; Ong KL; Kato T; Nakanishi Y; Ohno H; Liong MT
    Probiotics Antimicrob Proteins; 2020 Jun; 12(2):545-562. PubMed ID: 31301059
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Limosilactobacillus reuteri ameliorates preeclampsia in mice via improving gut dysbiosis and endothelial dysfunction.
    Li B; Shi Y; Qiu W; Lin Q; Zeng S; Hou Y; Zhou H; Chen M; Zhang D
    Biomed Pharmacother; 2023 May; 161():114429. PubMed ID: 36841030
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dietary Lactobacillus reuteri prevent from inflammation mediated apoptosis of liver via improving intestinal microbiota and bile acid metabolism.
    Lin Z; Wu J; Wang J; Levesque CL; Ma X
    Food Chem; 2023 Mar; 404(Pt B):134643. PubMed ID: 36283304
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of the anti-inflammatory Lactobacillus reuteri BM36301 and its probiotic benefits on aged mice.
    Lee J; Yang W; Hostetler A; Schultz N; Suckow MA; Stewart KL; Kim DD; Kim HS
    BMC Microbiol; 2016 Apr; 16():69. PubMed ID: 27095067
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Limosilactobacillus reuteri and caffeoylquinic acid synergistically promote adipose browning and ameliorate obesity-associated disorders.
    Liu Y; Zhong X; Lin S; Xu H; Liang X; Wang Y; Xu J; Wang K; Guo X; Wang J; Yu M; Li C; Xie C
    Microbiome; 2022 Dec; 10(1):226. PubMed ID: 36517893
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Limosilactobacillus reuteri SLZX19-12 Protects the Colon from Infection by Enhancing Stability of the Gut Microbiota and Barrier Integrity and Reducing Inflammation.
    Wu J; Lin Z; Wang X; Zhao Y; Zhao J; Liu H; Johnston LJ; Lu L; Ma X
    Microbiol Spectr; 2022 Jun; 10(3):e0212421. PubMed ID: 35658572
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.